Clinical Research Directory
Browse clinical research sites, groups, and studies.
Theoretically Informed Behavioral Intervention
Sponsor: Yale University
Summary
The goal of this waitlist control clinical trial is to learn if the tailored LEARN 2 platform can prevent HIV-related comorbidities with shared risk factors in men ages 18 and older living with HIV. The main question\[s\] are: 1. Can the virtual environment improve quality of life among these participants? 2. Does the LEARN 2 platform effectively serve as prevention education for HIV comorbidity shared risk factors? Researchers will compare participants receiving the LEARN2 virtual environment intervention to those in a waitlist control group to see if the intervention leads to improvements in quality of life and reductions in risk factors. Participants will be asked to: 1. Engage with the virtual environment weekly. 2. Participate in virtual live health educator sessions. 3. Complete daily assessments of personal health behaviors through Ecological Momentary Assessment.
Official title: Theoretically Informed Behavioral Intervention to Prevent HIV-related Comorbidities
Key Details
Gender
MALE
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
164
Start Date
2026-03-30
Completion Date
2029-03-31
Last Updated
2026-02-18
Healthy Volunteers
No
Conditions
Interventions
LEARN 2 Platform
The LEARN 2 Platform will provide tailored prevention education of HIV-comorbidities with shared risk factors. Participants will navigate LEARN 2 and access targeted health content.
Locations (1)
Yale University
Orange, Connecticut, United States